Proscia was founded in 2014 by a team out of Johns Hopkins and the University of Pittsburgh to improve clinical outcomes and accelerate the discovery of breakthrough advancements in the fight against cancer. Using modern computing technologies that unlock hidden data not visible to the human eye and turning that data into valuable insights in the fight against cancer, the company is dedicated to improving the efficiency, speed and quality of pathology diagnostics and research. 

Leadership Overview

Dave West, CEO
Nathan Buchbinder, Chief Product Officer
Coleman Stavish, Chief Technology Officer

For more information, visit